Suppr超能文献

关于使用线性无阈模型评估低剂量效应的争论。

The debate on the use of linear no threshold for assessing the effects of low doses.

作者信息

Tubiana M, Aurengo A, Averbeck D, Masse R

机构信息

Centre Antoine Béclère, 45 rue des Saints-Pères, 75006 Paris, France.

出版信息

J Radiol Prot. 2006 Sep;26(3):317-24. doi: 10.1088/0952-4746/26/3/N01. Epub 2006 Aug 22.

Abstract

From December 2004 to July 2005, three reports on the effects of low doses of ionising radiation were released: ICRP (2004), the joint report of the French Academies of Science and Medicine (Tubiana et al 2005), and a report from the American Academy of Sciences (BEIR VII 2005). These reports quote the same recent articles on the biological effects of low doses, yet their conclusions diverge. The French report concludes that recent biological data show that the efficacy of defense mechanisms is modulated by dose and dose rate and that linear no threshold (LNT) is no longer plausible. The ICRP and the BEIR VII reports recognise that there are biologic arguments against LNT but feel that there are not sufficient biological proofs against it to change risk assessment methodology and subsequent regulatory policy based on LNT. They point out the remaining uncertainties and the lack of mechanistic explanations of phenomena such as low dose hyperlethality or the adaptive response. In this context, a critical analysis of the available data is necessary. The epidemiological data and the experimental data challenge the validity of the LNT hypothesis for assessing the carcinogenic effect of low doses, but do not allow its exclusion. Therefore, the main criteria for selecting the most reliable dose-effect relationship from a scientific point of view should be based on biological data. Their analysis should help one to understand the current controversy.

摘要

2004年12月至2005年7月期间,发布了三份关于低剂量电离辐射影响的报告:国际放射防护委员会(ICRP,2004年)、法国科学院和医学科学院的联合报告(图比阿纳等人,2005年)以及美国科学院的一份报告(BEIR VII,2005年)。这些报告引用了关于低剂量生物效应的相同近期文章,但其结论却有所不同。法国报告得出结论,近期生物学数据表明防御机制的功效受剂量和剂量率调节,线性无阈(LNT)假设不再合理。ICRP和BEIR VII报告承认存在反对LNT的生物学论据,但认为没有足够的生物学证据反对它,从而改变基于LNT的风险评估方法和后续监管政策。他们指出了仍然存在的不确定性以及对低剂量超致死性或适应性反应等现象缺乏机制解释。在这种背景下,有必要对现有数据进行批判性分析。流行病学数据和实验数据对LNT假设用于评估低剂量致癌效应的有效性提出了挑战,但并不允许排除该假设。因此,从科学角度选择最可靠剂量 - 效应关系的主要标准应基于生物学数据。对这些数据的分析应有助于人们理解当前的争议。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验